ITEMS IN AFP WITH KEYWORD:

Anticoagulation

Jun 15, 2004 Issue
DVT and Pulmonary Embolism: Part II. Treatment and Prevention [Article]

Treatment goals for deep venous thrombosis include stopping clot propagation and preventing the recurrence of thrombus, the occurrence of pulmonary embolism, and the development of pulmonary hypertension, which can be a complication of multiple recurrent pulmonary emboli. About 30 percent of patient...


Mar 15, 2002 Issue
Is Thrombolytic Therapy Effective For Pulmonary Embolism? [Article]

Pulmonary embolism is a disorder that is associated with significant morbidity and mortality. Right-sided heart failure and recurrent pulmonary embolism are the main causes of death associated with pulmonary embolism in the first two weeks after the embolic event. Thrombolysis is a potentially lifes...


Feb 15, 1999 Issue
Low-Molecular-Weight Heparin in Treatment of DVT [Article]

Patients with a diagnosis of acute deep venous thrombosis have traditionally been hospitalized and treated with unfractionated heparin followed by oral anticoagulation therapy. Several clinical trials have shown that low-molecular-weight heparin is at least as safe and effective as unfractionated he...


Feb 1, 1999 Issue
Warfarin Therapy: Evolving Strategies in Anticoagulation [Article]

Warfarin is the oral anticoagulant most frequently used to control and prevent thromboembolic disorders. Prescribing the dose that both avoids hemorrhagic complications and achieves sufficient suppression of thrombosis requires a thorough understanding of the drug's unique pharmacology. Warfarin has...


Pages: Previous 1 2 3 4


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now